Heparin and concanavalin A interaction. A useful model for studying the mechanism of anticoagulant activity

Fil:Recondo, E.F. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.

Guardado en:

Detalles Bibliográficos
Autores principales:	Monge, J.C., Legorburu, C., Fernandez De Recondo, M., Recondo, E.F.
Formato:	JOUR
Lenguaje:	English
Materias:	concanavalin a heparin anticoagulation biological model drug interaction priority journal short survey
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_00778923_v556_n_p462_Monge
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Heparin and concanavalin A interaction. A useful model for studying the mechanism of anticoagulant activity
por: Recondo, Eduardo Francisco
Publicado: (1989)

Heparin and concanavalin A interaction: Isolation of fraction with higher anticoagulant activity
por: Fernandez de Recondo, M.E., et al.

Heparin and concanavalin A interaction: Isolation of fraction with higher anticoagulant activity
por: Recondo, Eduardo Francisco
Publicado: (1988)

Heparin and Concanavalin A interaction as a model for studying the mechanism of the anticoagulant activity
por: Monge, J.C., et al.

Heparin and Concanavalin A interaction as a model for studying the mechanism of the anticoagulant activity
por: Recondo, Eduardo Francisco
Publicado: (1989)

The active fraction of heparin enclose both properties: Anticoagulant and anticomplement
por: Recondo, Eduardo Francisco
Publicado: (2003)

The active fraction of heparin enclose both properties: Anticoagulant and anticomplement
por: Recondo, E.F., et al.

Antithrombin and first complement protein recognize the same active heparin fraction
por: Calabrese, G.C., et al.

Antithrombin and first complement protein recognize the same active heparin fraction
por: Recondo, Eduardo Francisco
Publicado: (2002)

A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein
por: Recondo, Eduardo Francisco
Publicado: (2004)

A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein
por: Calabrese, G.C., et al.

Low anticoagulant activity of high sulphated heparan sulphates
por: Kovensky, José Eduardo, et al.
Publicado: (1990)

Low anticoagulant activity of high sulphated heparan sulphates
por: Kovensky, J., et al.

Heparin-induced thrombocytopenia /
Publicado: (2013)

Heparin cofactor II, a thrombin inhibitor with a still unclarified physiologic role
por: Rossi, E.B., et al.

Heparin cofactor II, a thrombin inhibitor with a still unclarified physiologic role
Publicado: (1999)

Anticoagulant Activity of a Unique Sulfated Pyranosic (133) - ß - L - Arabinan through Direct Interaction with Thrombin

Anticoagulant Activity of a Unique Sulfated Pyranosic (133) - ß - L - Arabinan through Direct Interaction with Thrombin

Supramolecular assembly of glucose oxidase on concanavalin A-modified gold electrodes
Publicado: (2010)

Supramolecular assembly of glucose oxidase on concanavalin A-modified gold electrodes
por: Pallarola, D., et al.

Overview of anticoagulant activity of sulfated polysaccharides from seaweeds in relation to their structures, focusing on those of green seaweeds
por: Ciancia, Marina

Overview of anticoagulant activity of sulfated polysaccharides from seaweeds in relation to their structures, focusing on those of green seaweeds
por: Ciancia, Marina

Effects of anticoagulants on the immunological synapses of human autologous rosettes between macrophage and lymphocyte
por: Novak, Ivón T. C., et al.
Publicado: (2012)

Overview of anticoagulant activity of sulfated polysaccharides from seaweeds in relation to their structures, focusing on those of green seaweeds
por: Ciancia, Marina, et al.
Publicado: (2010)

Overview of anticoagulant activity of sulfated polysaccharides from seaweeds in relation to their structures, focusing on those of green seaweeds
por: Ciancia, M., et al.

Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins
Publicado: (1994)

Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins
por: Bertolesi, G.E., et al.

Heparin cofactor II in diabetic patients
por: Duboscq, C., et al.

Anticoagulant activity of a unique sulfated pyranosic (1→3)-β-L- arabinan through direct interaction with thrombin
por: Fernández, Paula Virginia, et al.
Publicado: (2013)

Anticoagulant activity of a unique sulfated pyranosic (1→3)-β-L- arabinan through direct interaction with thrombin
por: Fernández, P.V., et al.
Publicado: (2013)

Anticoagulant activity of a unique sulfated pyranosic (1→3)-β-L- arabinan through direct interaction with thrombin
por: Fernández, P.V., et al.

Anticoagulant activity of a unique sulfated pyranosic (1→3)-β-L- arabinan through direct interaction with thrombin
por: Fernández, P.V., et al.
Publicado: (2013)

Treatment of cerebrovascular disease with anticoagulants and platelet anti-aggregants
Publicado: (1999)

Treatment of cerebrovascular disease with anticoagulants and platelet anti-aggregants
por: Ameriso, S.F.

Heparin increases the adhesion of murine mammary adenocarcinoma cells (LM3). Correlation with the presence of heparin receptors on cell surface
por: Bertolesi, G., et al.

Unsuspected hyperhomocysteinemia in chronically anticoagulated patients
por: Murúa, A., et al.

Affinity chromatography on concanavalin a-sepharose of antigenic fractions of human seminal plasma
por: Mazzini, María Nélida, et al.
Publicado: (1979)

Affinity chromatography on concanavalin a-sepharose of antigenic fractions of human seminal plasma
por: Mazzini, M.N., et al.

Heparin cofactor II in diabetic patients
Publicado: (1994)

Intra- and Extracellular Biosynthesis and Characterization of Iron Nanoparticles from Prokaryotic Microorganisms with Anticoagulant Activity
Publicado: (2017)